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 We describe a case of juvenile idiopathic nonspecific in-
terstitial pneumonia (NSIP). This is the first report of a 
Japanese patient with idiopathic NSIP aged 27 years. A 
computed tomographic scan of the chest showed ground-
glass opacities and reticular opacities in subpleural distri-
bution. Bronchoalveolar lavage fluid revealed no specific 
finding except for decreased CD4/CD8 ratio of lymphocyte 
subset. Histopathological features on examination of 
thoracoscopic lung biopsy specimens were consistent with 
those of NSIP group III. The patient was treated with 
corticosteroids and immunosuppressants, but no clinical im-
provement was noted and the general condition has gradu-
ally worsened. Although the prognosis is generally consid-
ered to be good in patients with NSIP, some patients die as 
a result of progression of the disease. The prediction of 
prognosis based on histopathological, radiologic, and 
bronchoalveolar lavage cell findings in NSIP seems to be 
difficult at present. 
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Introduction
 Nonspecific interstitial pneumonia/fibrosis (NSIP) 
was first described by Katzenstein and Fiorelli in 
1994 as a diffuse interstitial pneumonia with a patho-
logic pattern distinct from usual, desquamative, and 
acute interstitial pneumonia". NSIP is characterized 
by an interstitial inflammatory cell infiltrate with or
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without fibrosis; however, the most characteristic find-
ing in NSIP is the lack of temporal heterogeneity, 
which is a cardinal feature of usual interstitial pneu-
monia (UIP)' - 6' . The prognosis in NSIP is generally 
good compared with UIP' -"), however it is reported 
that patients with NSIP group III have a worse prog-
nosis relative to those with NSIP groups I and II ' , 6 , 7 1 
NSIP occurs mainly in middle-aged adults 2' 3' 6 - 9>, like 
most other interstitial pneumonias. According to clini-
cal reports from Japan, the average age of patients at 
onset in NSIP is 56.4 to 57.7 years' 10'. We report 
here the first Japanese patient with early onset idio-
pathic NSIP group III.
Case Report
 A 27-year-old Japanese man was admitted to our 
hospital in June 1997 for further investigation of non-
productive cough and progressive exertional dyspnea. 
The medical history included bronchial asthma and 
atopic dermatitis during childhood. The father died of 
the progressive idiopathic pulmonary fibrosis (IPF) 
and diagnosed as UIP at autopsy. The uncle also died 
of IPF. The patient was a tobacco smoker (40 ciga-
rettes a day) for 8 years, but reported no environ-
mental exposure to chemicals. 
 Physical examination was otherwise normal apart 
from bilateral basilar inspiratory fine crackles on 
chest examination. Although reticulonodular opacities 
were detected on the chest X-ray film in November 
1996, the patient was not admitted to the hospital. 
Chest X-ray film on admission showed diffuse 
reticulonodular opacities in both middle and lower 
lung fields (Fig. 1). A computed tomographic scan of 
the chest showed ground-glass opacities and reticular 
opacities in subpleural distribution (Fig. 2). The rele-
vant laboratory results included lactic dehydrogenase
Figure 1. Chest X-ray taken at the time of diagnosis in 1997 
showing diffuse reticulonodular opacities in both middle and 
lower lung fields.
459 IU/L (normal range 202-435) and C-reactive pro-
tein 0.32 mg/dl (normal; negative). Antinuclear anti-
bodies were positive (X40, speckled type), while rheu-
matoid factor and other specific antibodies for 
collagen vascular diseases were negative. Arterial 
blood gases on room air at rest were PaO 2 87.5 
mmHg, PaCO 2 45.5 mmHg, and pH 7.376. 
 Pulmonary-function tests included vital capacity of 
3.39 L (80.3 percent of predicted), FEV i of 2.98 L (89.5 
percent of predicted), DLCO/VA of 4.092 ml/M/mmHg/ 
L, and %DLCO 46.8 percent. Bronchoalveolar lavage 
(BAL) was performed using 200 ml of physiological 
saline. Examination of BAL fluid showed 4.1 X 10 5 
cells/ml including 82.6 percent macrophages, 0.3 per-
cent neutrophils, 0.4 percent basophils, 3.8 percent 
eosinophils, and 12.9 percent lymphocytes. The 
CD4/CD8 ratio of lymphocyte subset was 0.44. 
 To establish a definite diagnosis, lung biopsy was 
performed by video-assisted thoracoscopic surgery on 
June 16, 1997. Pathological diagnosis was made as
Figure 2. A computed tomographic scan of the chest at the 
time of diagnosis in 1997 showing ground-glass opacities and 
reticular opacities in subpleural distribution.
Figure 3. Specimen obtained by thoracoscopic lung biopsy 
showing a mild degree of intra-airspace organization, the 
presence of minimal fibrosis, and subpleural honeycombing 
with loss of alveolar structure. Compared to UIP, temporal 
heterogeneity of the fibrous tissue was absent (HE stain, A 
X5, BX33).
NSIP group Ill, based on the findings that lung tissue 
obtained from the left lower lobe showed a mild de-
gree of intra-airspace organization, the presence of 
minimal fibrosis, and subpleural honeycombing with 
loss of alveolar structure. Compared to UIP, temporal 
heterogeneity of the fibrous tissue was absent (Fig. 3). 
Since dust inhalation and collagen vascular disease 
were ruled out, the diagnosis was idiopathic NSIP 
group 1H. 
 Oral prednisolone was administered at 1 mg/kg/-
day. Although such therapy was initially effective, de-
terioration of the clinical condition and worsening of
interstitial pneumonia occurred following tapering of 
prednisolone. Accordingly, the patient was treated 
with a high dose of methyl prednisolone (1 g/day in-
travenously for three days) followed by oral 
corticosteroids, combined with oral immunosuppressant
Figure 4. Chest X-ray taken in 2000 showing diffuse reticu-
lar opacities and elevation of both domes of the diaphragm 
indicative of lung volume loss.
Figure 5. High resolution computed tomography of the chest 
taken in 2000 showing diffuse ground-glass opacities with 
honeycomb formation, local traction bronchiectasis, and inter-
lobular septal thickening.
Figure 6. Summary of clinical course. 
Therapeutic intervention, arterial blood 
gases, pulmonary function tests, and 
schema of chest X-ray films. BAL: 
bronchoalveolar lavage, VATS: video-
assisted thoracoscopic surgery, HOT: 
home oxygen therapy, PSL: prednisolone, 
m-PSL: methyl prednisolone, AZP: 
azathioprine. CYA: cvclosporin.
(either azathioprine 50 mg/day, or cyclosporin 200 
mg/day). However, at that stage, NSIP showed resis-
tance to treatment. Follow-up examination in March 
2000 showed arterial blood gases on room air of Pa0 2 of 
48.1 mmHg, PaCO 2 of 39.8 mmHg and pH of 7.443, 
and serum KL-6 of 2,320 U/ml. Chest X-ray film 
showed diffuse reticular opacities in both lung fields 
and lung volume loss (Fig. 4), and high resolution 
computed tomography of the chest showed diffuse 
ground-glass opacities with honeycomb formation, 
local traction bronchiectasis, and interlobular septal 
thickening (Fig. 5). At present, the patient is on home 
oxygen therapy and on the waiting list for lung trans-
plantation. Figure 6 provides a summary of the clini-
cal course of this case.
described) of Nakamura et al." (Table 1). In our insti-
tution, the average age at onset of patients with idio-
pathic NSIP is similar to those of the above two 
Japanese studies (52.9 years, range, 27 to 65 yr) (Table 
1). However, there is no report so far that described 
the clinical course of juvenile idiopathic NSIP. To our 
knowledge, therefore, this is the first report of a 
Japanese patient with early onset idiopathic NSIP. 
Although the present case was suspected to be a he-
reditary interstitial lung disease, this could not be 
confirmed because of lack of detailed genetic examina-
tions.
Table 1. Age at Onset of Patients with Idiopathic Nonspecific 
Interstitial Pneumonia/Fibrosis (NSIP) reported in Japan.
Discussion
 Nonspecific interstitial pneumonia/fibrosis (NSIP) 
was first defined by Katzenstein and Fiorelli in 1994'), 
and the name has gained broad acceptance 4 , ". The 
prognosis is generally good in NSIP patients, but some 
patients, especially those of group II and III of NSIP 
die as a result of progression of the disease"""'. 
Recently, Travis et al.4 proposed that NSIP should be 
separated into cellular and fibrosing patterns because 
these histological patterns are associated with disease 
characteristics and prognosis. Based on the proposed 
category of NSIP, the cellular pattern generally corre-
sponds to group I and fibrosing pattern to group II 
and III of NSIP, initially described by Katzenstein and 
Fiorelli ". They also reported that only patients with 
idiopathic cellular NSIP has an excellent long-term 
prognosis, and that the majority of patients with idio-
pathic NSIP fibrosing pattern die mostly within 5 and 
10 years4'. However, the prediction of prognosis based 
on histopathological, radiologic or bronchoalveolar 
lavage cell findings in NSIP seems to be difficult at 
present. Future studies need to evaluate this issue 
clinicopathologically in a large population of NSIP. 
 NSIP occurs most often in middle-aged adults""'). 
Although the disease could affect individuals at any 
age, cases of juvenile NSIP are comparatively rare. 
Several juvenile patients with NSIP were reported by 
Katzenstein and Fiorelli' ), while connective-tissue dis-
eases were also included in their report. According to 
recent reports of idiopathic NSIP, the average age at 
onset was 57 years (range, 40 to 73) in the study of 
Bjoraker et al.') and 43 years (range, 31 to 66) of 
Daniil et al.'). Furthermore, the age of affected 
Japanese patients is 57.7 years (range, 40 to 69) ac-
cording to Nagai et al.') and 56.4 years (range, not
  Reference Overall Group I Group I/II Group 11/RI Group III 
 Nagai et al.' 57.7±8.2* 46.50t 57.7±8.0* 58.4±8.0* 57.8±8.7* 
              (n=31) (n=2) (n=16) (n=29) (n=15) 
Nakamura et al.' 56.4±9.97* 65.8±8.89* ND 54.0±8.75 ND 
              (n=30) (n=6) (n=24) 
  Our cases 52.9±12.9* 57t 52.9±12.9* 51.7± 14.6* 
               (n=9) (n=0) (n=2) (n=9) (n=7)
*: Mean ± SD, t: average, ND: not described
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